原发性硬化性胆管炎是一种病因不明的少见疾病。
Primary sclerosing cholangitis (PSC) is a rare disease of uncertain origin.
胆管造影是原发性硬化性胆管炎诊断的参考指标。
Cholangiography is the reference standard for the diagnosis of primary sclerosing cholangitis.
荧光原位杂交检测原发性硬化性胆管炎：有用的检测还是随机选择的结果？
Fluorescent in situ hybridization testing in primary sclerosing cholangitis: Useful testing or a random chance result?
肝移植是迄今为止已知的治疗因原发性硬化性胆管炎(PSC)导致的终末期肝病的唯一的治愈疗法。
Liver transplantation is the only curative treatment known to date for end-stage liver disease occurring as a result of primary sclerosing cholangitis (PSC).
本文就原发性硬化性胆管炎的治疗作一综述，以期加深对该病 的了解，为进一步的临床治疗提供依据。
This article introduces the studies of the therapy of PSC to further understand the disease of PSC and provide new evidences for treating PSC.
三个溃疡性结肠炎易感性基因座与原发性硬化性胆管炎相关，并表明IL2，REL和CARD9的作用。
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9
三个溃疡性结肠炎易感性基因座与原发性硬化性胆管炎相关，并表明IL2，REL和CARD9的作用。
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9
应用推荐